Skip to content

13F-HR filed by KVP Capital Advisors, LP

KVP Capital Advisors, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 11:40:49 UTC, with 36 holding rows worth $124,289,546.

Accession
0001104659-26-127594
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 36 entries on the cover page, a total value of $124,289,546 stated on the cover page (in dollars after the unit check, H1), rows summing to $124,289,546 with VALUE read as dollars as filed, 13F file number 028-26641. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PRAXIS PRECISION MEDICINES I74006W207COM NEW42,900$12,493,767dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN2,165,997$8,144,149dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS684,123$7,477,464dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM53,000$7,467,170dollars as filed
MBX BIOSCIENCES INC COM55287L101Stock121,524$7,123,737dollars as filed
ERASCA INC COM29479A108Stock455,000$6,670,300dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock414,000$5,928,480dollars as filed
TANGO THERAPEUTICS INC87583X109COM230,264$5,745,087dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM133,000$5,399,800dollars as filed
TANDEM DIABETES CARE INC875372203COM NEW301,000$4,909,310dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK462,355$3,740,452dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK226,575$3,650,123dollars as filed
INSMED INC COM PAR $.01457669307Stock28,497$3,252,648dollars as filed
SAVARA INC805111101COM605,280$3,123,244dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM102,000$3,088,560dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock79,700$3,062,074dollars as filed
DISC MEDICINE INC COM254604101Stock43,750$2,863,875dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock4,750$2,573,978dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM125,000$2,573,750dollars as filed
IMMIX BIOPHARMA INC45258H106COMMON STOCK230,423$2,397,551dollars as filed
DESIGN THERAPEUTICS INC25056L103COM185,000$2,325,450dollars as filed
OCULAR THERAPEUTIX INC67576A100COM300,000$2,301,000dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM39,000$2,296,320dollars as filed
MINERALYS THERAPEUTICS INC603170101COM84,168$2,115,142dollars as filed
VOGENX INC92859A106COM86,069$1,961,513dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK26,900$1,628,661dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK31,813$1,584,924dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK373,128$1,552,212dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM200,000$1,424,000dollars as filed
EVOLUS INC30052C107COM150,000$1,200,000dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK32,700$1,055,883dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK505,431$970,428dollars as filed
ADIAL PHARMACEUTICALS INC00688A304COM NEW210,256$843,127dollars as filed
COMPASS THERAPEUTICS INC20454B104COM771,000$801,840dollars as filed
CELCUITY INC15102K100COM4,000$318,080dollars as filed
Yarrow Bioscience, Inc.92941V407Common Stock, $0.0001 par value10,011$225,447dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-127594this filing2026-11-16